Please login to the form below

Not currently logged in
Email:
Password:

Helen Parfitt joins Research Partnership

She takes on role as head of its Therapy Watch market tracking tool

Helen ParfittResearch Partnership has appointed Helen Parfitt as its new director, head of Therapy Watch - a ‘real-time’ syndicated global market tracking tool - in a role that will see her based at the firm’s head office in London.

Prior to joining the company, Parfitt has previously worked for IMS Health (now QuintilesIMS) as its director of core data assets, global technology services and operations, and subsequently as commercial director for M3 Group’s European division.

Her new role will see her join research directors Julia Godfrey and Laurent Chanroux in supporting the continued expansion of Therapy Watch, which currently runs global monitors in auto-immune, virology, oncology and nephrology.

She will also focus on the firm’s recently expanded oncology portfolio, which has added squamous cell carcinoma of the head and neck (SCCHN) and chronic myeloid leukaemia (CML) to its coverage.

Mark Jeffery, founding director of Research Partnership, said: “Helen brings with her a wealth of knowledge and expertise, her experience at GSK and Schering-Plough means she has also developed a strong understanding of clients’ needs.

“I believe she will be a strong asset to the Therapy Watch team and we look forward to her contributing to its continued growth and development.”

8th May 2017

From: Marketing

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...